PMID- 37964437 OWN - NLM STAT- MEDLINE DCOM- 20240305 LR - 20240305 IS - 1469-8978 (Electronic) IS - 0033-2917 (Linking) VI - 54 IP - 4 DP - 2024 Mar TI - Near-infrared spectroscopy and electroencephalography neurofeedback for binge-eating disorder: an exploratory randomized trial. PG - 675-686 LID - 10.1017/S0033291723002350 [doi] AB - BACKGROUND: Binge-eating disorder (BED) co-occurs with neurobehavioral alterations in the processing of disorder-relevant content such as visual food stimuli. Whether neurofeedback (NF) directly targeting them is suited for treatment remains unclear. This study sought to determine feasibility and estimate effects of individualized, functional near-infrared spectroscopy-based real-time NF (rtfNIRS-NF) and high-beta electroencephalography-based NF (EEG-NF), assuming superiority over waitlist (WL). METHODS: Single-center, assessor-blinded feasibility study with randomization to rtfNIRS-NF, EEG-NF, or WL and assessments at baseline (t0), postassessment (t1), and 6-month follow-up (t2). NF comprised 12 60-min food-specific rtfNIRS-NF or EEG-NF sessions over 8 weeks. Primary outcome was the binge-eating frequency at t1 assessed interview-based. Secondary outcomes included feasibility, eating disorder symptoms, mental and physical health, weight management-related behavior, executive functions, and brain activity at t1 and t2. RESULTS: In 72 patients (intent-to-treat), the results showed feasibility of NF regarding recruitment, attrition, adherence, compliance, acceptance, and assessment completion. Binge eating improved at t1 by -8.0 episodes, without superiority of NF v. WL (-0.8 episodes, 95% CI -2.4 to 4.0), but with improved estimates in NF at t2 relative to t1. NF was better than WL for food craving, anxiety symptoms, and body mass index, but overall effects were mostly small. Brain activity changes were near zero. CONCLUSIONS: The results show feasibility of food-specific rtfNIRS-NF and EEG-NF in BED, and no posttreatment differences v. WL, but possible continued improvement of binge eating. Confirmatory and mechanistic evidence is warranted in a double-blind randomized design with long-term follow-up, considering dose-response relationships and modes of delivery. FAU - Hilbert, Anja AU - Hilbert A AUID- ORCID: 0000-0003-2775-1296 AD - Integrated Research and Treatment Center AdiposityDiseases, Behavioral Medicine Research Unit, Department of Psychosomatic Medicine and Psychotherapy, Leipzig University Medical Center, Leipzig, Germany. FAU - Rosch, Sarah Alica AU - Rosch SA AUID- ORCID: 0000-0001-5439-8147 AD - Integrated Research and Treatment Center AdiposityDiseases, Behavioral Medicine Research Unit, Department of Psychosomatic Medicine and Psychotherapy, Leipzig University Medical Center, Leipzig, Germany. FAU - Petroff, David AU - Petroff D AD - Clinical Trial Centre Leipzig, University of Leipzig, Leipzig, Germany. FAU - Prettin, Christiane AU - Prettin C AD - Clinical Trial Centre Leipzig, University of Leipzig, Leipzig, Germany. FAU - Luhrs, Michael AU - Luhrs M AD - Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. AD - Brain Innovation B.V., Maastricht, The Netherlands. FAU - Ehlis, Ann-Christin AU - Ehlis AC AD - Department of Psychiatry and Psychotherapy, University Hospital of Tuebingen, Tuebingen, Germany. FAU - Schmidt, Ricarda AU - Schmidt R AUID- ORCID: 0000-0001-7794-2897 AD - Integrated Research and Treatment Center AdiposityDiseases, Behavioral Medicine Research Unit, Department of Psychosomatic Medicine and Psychotherapy, Leipzig University Medical Center, Leipzig, Germany. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20231115 PL - England TA - Psychol Med JT - Psychological medicine JID - 1254142 SB - IM MH - Humans MH - *Binge-Eating Disorder/therapy MH - *Neurofeedback/methods MH - Obesity MH - Spectroscopy, Near-Infrared MH - Electroencephalography MH - *Bulimia MH - Treatment Outcome OTO - NOTNLM OT - binge-eating disorder OT - electroencephalography OT - near-infrared spectroscopy OT - neurofeedback OT - obesity OT - treatment EDAT- 2023/11/15 06:42 MHDA- 2024/03/05 06:47 CRDT- 2023/11/15 00:06 PHST- 2024/03/05 06:47 [medline] PHST- 2023/11/15 06:42 [pubmed] PHST- 2023/11/15 00:06 [entrez] AID - S0033291723002350 [pii] AID - 10.1017/S0033291723002350 [doi] PST - ppublish SO - Psychol Med. 2024 Mar;54(4):675-686. doi: 10.1017/S0033291723002350. Epub 2023 Nov 15.